Verhalten älterer Frauen bezüglich der Vorsoorge des Mammacarcinoms

Breast cancer is primarily a disease of older women and the risk increases with age. In aging populations, breast cancer is a major public health concern. Researches regarding breast cancer screening and therapy have not included elderly women, and epidemiologic studies of screening in elderly women...

全面介绍

Gespeichert in:
书目详细资料
主要作者: El-Balat, Ahmed
其他作者: Kolb, Gerald (Prof. Dr. Dr.) (BetreuerIn (Doktorarbeit))
格式: Dissertation
语言:German
出版: Philipps-Universität Marburg 2012
主题:
在线阅读:PDF-Volltext
标签: 添加标签
没有标签, 成为第一个标记此记录!
实物特征
总结:Breast cancer is primarily a disease of older women and the risk increases with age. In aging populations, breast cancer is a major public health concern. Researches regarding breast cancer screening and therapy have not included elderly women, and epidemiologic studies of screening in elderly women demonstrate that screening is not consistently used. Subsequently elderly women are often under diagnosed and under treated. In order to identify the causes of the reluctance in the elderly population towards the breast cancer screening we investigated the attitudinal components of health-related behavior of 200 women in Germany and in Egypt and compared two different age groups below and above the age of 69 years. The results of our study showed differences between both age groups in both countries regarding the knowledge about breast cancer and breast cancer screening, which consequently influenced the behavior and practice towards the screening. Old women in Egypt and Germany did not believe in the importance of treating breast cancer with aging and believed lesser in a better quality of life after treatment. After an informative confrontation elderly women admitted their willingness to participate more in screening which will underline the important role of education and information. Conclusions: According to our results we will recommend more focus on the elderly to be better informed and encouraged to participate in the screening program of breast cancer.
DOI:10.17192/z2012.0456